##  [Novartis Phase III Study Shows ACZ885 Helped Substantially Reduce Steroid Use in 45% of Patients With Serious Form of Childhood Arthritis](/us-en/news/media-releases/novartis-phase-iii-study-shows-acz885-helped-substantially-reduce-steroid-use-45-patients-serious-form-childhood-arthritis-0 "Novartis Phase III Study Shows ACZ885 Helped Substantially Reduce Steroid Use in 45% of Patients With Serious Form of Childhood Arthritis") 

  Nov 07, 2011